Conv. Plasma
Nigella Sativa

All vitamin D studies
Meta analysis
study COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Serum Vitamin D Concentrations in CoVID19 Patients

Azadeh et al., J. Mazandaran Univ. Med. Sci. 31:195
Apr 2021  
  Source   PDF   All Studies   Meta AnalysisMeta
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020
*, now known with p < 0.00000000001 from 120 studies, recognized in 8 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,000+ studies for 60+ treatments.
Retrospective 80 COVID-19 patients in Iran and 70 healthy controls, showing significantly lower vitamin D levels in COVID-19 patients.
Azadeh et al., 30 Apr 2021, Iran, peer-reviewed, 6 authors.
This PaperVitamin DAll
Serum Vitamin D Concentrations in CoVID19 Patients
Hossein Azadeh, Akbar Hedayatizadeh-Omran, Majid Saeedi, Laleh Vahedi-Larijani, Hossein Mehravaran, Keyvan Heydari
Background and purpose: Vitamin D deficiency is highly prevalent in Iran. Death toll due to the Coronavirus Disease 2019 (COVID-19) is high in this country. The purpose of the present investigation was to provide more information on the relationship between serum levels of vitamin D in confirmed cases of COVID-19 in north of Iran. Materials and methods: This cross-sectional descriptive study was performed in COVID-19 patients (n=80) attending Sari Imam Khomeini Hospital, Iran 2020, who were confirmed for COVID-19 infection with CT-Scan or RT-PCR. Seventy healthy individuals were also examined as the control group. SPSS V19 was applied for data analysis. Results: In this study, 80 patients with COVID-19 (mean age: 57.22 ± 17.44 years old) and 70 healthy individuals (mean age: 48.69 ± 12.99 years) were studied. There were 38 and 35 males in these two groups, respectively. Serum Vitamin D levels were significantly lower in patients with COVID-19 than those in the control group (18.72 ± 12.53 vs. 30.86 ± 15.19 ng/ml, P< 0.001). Conclusion: This study showed that serum levels of Vitamin D were lower in patients with COVID-19 than healthy individuals and frequency of Vitamin D deficiency was higher in these patients. Hence, further studies are needed to clarify the role of serum Vitamin D concentrations in patients with COVID-19 infection.
Alipio, Vitamin D Supplementation Could Possibly Improve Clinical Outcomes of Patients Infected with Coronavirus
Andersen, Rambaut, Lipkin, Holmes, Garry, The proximal origin of SARS-CoV-2, Nature Medicine
Baktash, Hosack, Patel, Shah, Kandiah et al., Vitamin D status and outcomes for hospitalised older patients with COVID-19, Postgrad Med J
D'avolio, Avataneo, Manca, Cusato, Nicolò et al., 25-hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2, Nutrients
Faul, Kerley, Love, Neill, Cody et al., Vitamin D deficiency and ARDS after SARS-CoV-2 infection, Ir Med J
Ghasemian, Shamshirian, Heydari, Malekan, Alizadeh-Navaei et al., The Role of Vitamin D in The Age of COVID-19: A Systematic Review and Meta-Analysis Along with an Ecological Approach, MedRxiv
Ginde, Mansbach, Camargo, Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey, Arch intern Med
Hastie, Mackay, Ho, Celis-Morales, Katikireddi et al., Vitamin D concentrations and COVID-19 infection in UK Biobank, Diabetes Metab Syndr
Hedayatizadeh Omran, Janbabaei, Navaei, Amjadi, Izadi et al., Association between prechemotherapy serum levels of vitamin D and clinicopathologic findings in gastric cancer, Caspian J Intern Med
Hessami, Shamshirian, Heydari, Pourali, Alizadeh-Navaei et al., Cardiovascular diseases burden in COVID-19: Systematic review and metaanalysis, Am J Emerg Med
Holman, Knighton, Kar, 'keefe, Curley et al., Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study, The lancet Diabetes & Endocrinology
Huang, Wang, Li, Ren, Zhao et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, The Lancet
Im, Je, Baek, Chung, Kwon et al., Nutritional status of patients with coronavirus disease
Kohlmeier, Avoidance of vitamin D deficiency to slow the COVID-19 pandemic
Mcintosh, Hirsch, Bloom, Coronavirus disease 2019(COVID-19): Epidemiology, virology, and prevention, Lancet Infect Dis
Mehta, Mcauley, Brown, Sanchez, Tattersall et al., COVID-19: consider cytokine storm syndromes and immunosuppression, Lancet
Mosekilde, Vitamin D and the elderly, Clin Endocrinol
Orwoll, Nielson, Marshall, Lambert, Holton et al., Vitamin D deficiency in older men, J Clin Endocrinol Metab
Rhodes, Dunstan, Laird, Subramanian, Kenny, COVID-19 mortality increases with northerly latitude after adjustment for age suggesting a link with ultraviolet and vitamin D, Prevention & Health
Tabrizi, Moosazadeh, Akbari, Dabbaghmanesh, Mohamadkhani et al., High prevalence of vitamin D deficiency among Iranian population: a systematic review and meta-analysis, Iran J Med Sci
Vignera, Cannarella, Condorelli, Torre, Aversa et al., Sex-specific SARS-CoV-2 mortality: among hormonemodulated ACE2 expression, risk of venous thromboembolism and hypovitaminosis d, Int J Mol Sci
Zdrenghea, Makrinioti, Bagacean, Bush, Johnston et al., Vitamin D modulation of innate immune responses to respiratory viral infections, Reviews in medical virology
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop